Cite
Supplementary Figure 1 from A Phase I First-in-Human Trial of Bardoxolone Methyl in Patients with Advanced Solid Tumors and Lymphomas
MLA
Bruce J. Dezube, et al. Supplementary Figure 1 from A Phase I First-in-Human Trial of Bardoxolone Methyl in Patients with Advanced Solid Tumors and Lymphomas. Mar. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3c178227e7ccf337055099e0fff52495&authtype=sso&custid=ns315887.
APA
Bruce J. Dezube, Geoffrey I. Shapiro, Hillard Lazarus, Donald Kufe, Michael Andreeff, Sergej Konoplev, Marina Konopleva, James Mier, Deborah A. Ferguson, Colin J. Meyer, Joseph Paul Eder, Donald Lawrence, Jennifer Wheler, Aung Naing, Xiaoying He, Jeffrey G. Supko, Razelle Kurzrock, & David S. Hong. (2023). Supplementary Figure 1 from A Phase I First-in-Human Trial of Bardoxolone Methyl in Patients with Advanced Solid Tumors and Lymphomas.
Chicago
Bruce J. Dezube, Geoffrey I. Shapiro, Hillard Lazarus, Donald Kufe, Michael Andreeff, Sergej Konoplev, Marina Konopleva, et al. 2023. “Supplementary Figure 1 from A Phase I First-in-Human Trial of Bardoxolone Methyl in Patients with Advanced Solid Tumors and Lymphomas,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3c178227e7ccf337055099e0fff52495&authtype=sso&custid=ns315887.